TNFRSF9 and infection: Multiple studies have demonstrated that stimulating 4-1BB signaling results in the anti-pathogenic immune responses against infections, including those of Streptococcus pneumoniae, Listeria monocytogenes, Candida albicans, influenza virus, hepatitis C virus, and cytomegalovirus (63–67).